@marrow.bsky.social
Haematologist with particular interests in BMT, PNH and Gaucher disease.
IMJ November (Vol 55, Iss 11) is now online
bit.ly/47HoPbI
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ September 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified?
bit.ly/3K3qDDO
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Review: Replacement therapy in congenital adrenal hyperplasia
bit.ly/3HF9KPi
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Original Article: In-hospital cardiac arrest
bit.ly/4p5P8QZ
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Original Article: Is incidence and burden of cancer increasing among young individuals?
bit.ly/4p88bdh
@theracp.bsky.social
IMJ September 2025 #OpenAccess
Original Article: Automatic screening for viral hepatitis in an Emergency Department
bit.ly/46h53EB
@theracp.bsky.social
IMJ September 2025 #FreeAccess
Original Article: Lung transplantation for interstitial lung diseases
bit.ly/3JELX2B
@theracp.bsky.social
IMJ October 2025 #OpenAccess
Editor's Choice (Clinical Perspective): Hyperhidrosis: donโt sweat it
bit.ly/42uVLmg
@theracp.bsky.social
IMJ October 2025 #FreeAccess
Editorial: A, B, C or D? Goals of Care: a need for a national structural framework.
bit.ly/46JpvOI
@theracp.bsky.social
A bumper issue of @the-imj.bsky.social Congratulations.
13.10.2025 09:23 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
IMJ September (Volume 55, Issue 9) is now online
bit.ly/45ZaKpj
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ August 2025 #FreeAccess
Editor's Choice (Original Article): Glomerular disease registry and Biobank
bit.ly/3ULSydE
@theracp.bsky.social @marrow.bsky.social @sunilbadve.bsky.social
IMJ August 2025 #OpenAccess
Original Article: Hyperuricaemia in Type 1 Gaucher disease
bit.ly/3Hl6zMi
@theracp.bsky.social @marrow.bsky.social
IMJ August (Vol 55, Iss 8) is now online
bit.ly/3J5Ndvm
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ July 2025 #OpenAccess
Editor's choice (review): Generative artificial intelligence in healthcare
bit.ly/4loWVXS
@theracp.bsky.social
GenAI in clinical healthcare could be transformative. However, numerous challenges exist including technological, regulatory, workforce adaption, and trust.
IMJ July 2025 #FreeAccess
Editorial: Are Australians Living with Dementia Ready for New Therapies?
bit.ly/4eEYE8M
@theracp.bsky.social
IMJ July 2025 #OpenAccess
Original Article: Alzheimer disease: rollout of amyloid-targeting therapies
bit.ly/3Il89Oq
@theracp.bsky.social
IMJ July 2025 #FreeAccess
Clinical Perspective: Management of pulmonary fibrosis
bit.ly/3IkW7EO
@theracp.bsky.social
New research is expanding pulmonary fibrosis treatment beyond IPF to other fibrotic ILDs, integrating targeted drugs and immunomodulation.
IMJ July 2025 #OpenAccess
Original article: โNo man's landโ โ transition to adulthood for young adults with complex health needs
bit.ly/4nITRaC
@theracp.bsky.social
IMJ July 2025 #OpenAccess
Original Article: Terminal heart failure care for women
bit.ly/44UDDDH
@theracp.bsky.social
IMJ July 2025 #OpenAccess
Original Article: Allogeneic haemopoietic stem cell transplantation for patients with chronic lymphocytic leukaemia
bit.ly/3Iltfw0
@theracp.bsky.social
IMJ July (Vol 55, Iss 7) is now online
bit.ly/3U2KC7s
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
Want to learn about the prevention of thrombosis in patients with PNH?๐ฉธ
Make sure to watch our recent interview from #IPIG2025 with @marrow.bsky.socialโฌ of @petermaccc.bsky.socialโฌ in which he discusses this:
๐ฅ buff.ly/i8Ry0Zr
#RareDisease #Hematology #Thrombosis #BloodSky #MedSky
IMJ June 2025 #FreeAccess
Editorial: "Two decades at the helm: it only seems like a few weeks". Former Editor-in-Chief (now Emeritus Editor) Jeff Szer looks back at his many years on the IMJ.
bit.ly/3FNAg86
@theracp.bsky.social
@marrow.bsky.social
IMJ May 2025 #OpenAccess
Editor's choice (clinical perspective): Chimeric antigen-T cells and bispecific antibodies
bit.ly/3Z3Hrj1
@theracp.bsky.social @marrow.bsky.social
IMJ May (Vol 55, Iss 5) is now online
bit.ly/4iVn7XW
@theracp.bsky.social
@marrow.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
IMJ April 2025 #FreeAccess
Review: Telehealth research trends in Australia
bit.ly/3R9ZyPM
@marrow.bsky.social @theracp.bsky.social
IMJ April 2025 #FreeAccess
Editorial: Climate stewardship in healthcare.
Health professionals need to walk the talk in climate change behaviour modelling.
bit.ly/3G0TuXB
@marrow.bsky.social @theracp.bsky.social
IMJ Apr 2025 #FreeAccess
Editor's choice (original article): Cerebral microbleeds in an Australian Memory clinic
bit.ly/4cxFzo8
@marrow.bsky.social @theracp.bsky.social
IMJ April (Vol 55, Issue 4) is now online
bit.ly/3R38tCq
@marrow.bsky.social @theracp.bsky.social @ianjohnwoolley.bsky.social @andrewmallett8.bsky.social @sunilbadve.bsky.social
